• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MAL启动子高甲基化作为胃癌的一种新型预后标志物

MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.

作者信息

Buffart T E, Overmeer R M, Steenbergen R D M, Tijssen M, van Grieken N C T, Snijders P J F, Grabsch H I, van de Velde C J H, Carvalho B, Meijer G A

机构信息

Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands.

出版信息

Br J Cancer. 2008 Dec 2;99(11):1802-7. doi: 10.1038/sj.bjc.6604777. Epub 2008 Nov 11.

DOI:10.1038/sj.bjc.6604777
PMID:19002170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2600687/
Abstract

T-lymphocyte maturation associated protein, MAL, has been described as a tumour-suppressor gene with diagnostic value in colorectal and oesophageal cancers, and can be inactivated by promoter hypermethylation. The aim of this study was to analyse the prevalence of MAL promoter hypermethylation and the association with mRNA expression in gastric cancers and to correlate methylation status to clinicopathological data. Bisulphite-treated DNA isolated from formalin-fixed and paraffin-embedded samples of 202 gastric adenocarcinomas and 22 normal gastric mucosae was subjected to real-time methylation-specific PCR (Q-MSP). Two regions within the MAL promoter (M1 and M2) were analysed. In addition, 17 frozen gastric carcinomas and two gastric cancer cell lines were analysed both by Q-MSP and real-time RT-PCR. Methylation of M1 and M2 occurred in 71 and 80% of the gastric cancers, respectively, but not in normal gastric mucosa tissue. Hypermethylation of M2, but not M1, correlated with significantly better disease-free survival in a univariate (P=0.03) and multivariate analysis (P=0.03) and with downregulation of expression (P=0.01). These results indicate that MAL has a putative tumour-suppressor gene function in gastric cancer, and detection of promoter hypermethylation may be useful as a prognostic marker.

摘要

T淋巴细胞成熟相关蛋白(MAL)已被描述为一种在结直肠癌和食管癌中具有诊断价值的肿瘤抑制基因,且可因启动子高甲基化而失活。本研究旨在分析MAL启动子高甲基化在胃癌中的发生率及其与mRNA表达的关系,并将甲基化状态与临床病理数据相关联。从202例胃腺癌和22例正常胃黏膜的福尔马林固定石蜡包埋样本中提取经亚硫酸氢盐处理的DNA,进行实时甲基化特异性PCR(Q-MSP)。分析了MAL启动子内的两个区域(M1和M2)。此外,对17例冷冻胃癌和两个胃癌细胞系进行了Q-MSP和实时逆转录PCR分析。M1和M2的甲基化分别发生在71%和80%的胃癌中,但在正常胃黏膜组织中未发生。M2而非M1的高甲基化在单因素分析(P=0.03)和多因素分析(P=0.03)中与显著更好的无病生存率相关,且与表达下调相关(P=0.01)。这些结果表明,MAL在胃癌中具有假定的肿瘤抑制基因功能,并提示启动子高甲基化检测可能作为一种预后标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c2/2600687/5699822a65e4/6604777f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c2/2600687/a5a267153f27/6604777f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c2/2600687/d97575305101/6604777f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c2/2600687/5699822a65e4/6604777f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c2/2600687/a5a267153f27/6604777f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c2/2600687/d97575305101/6604777f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2c2/2600687/5699822a65e4/6604777f3.jpg

相似文献

1
MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.MAL启动子高甲基化作为胃癌的一种新型预后标志物
Br J Cancer. 2008 Dec 2;99(11):1802-7. doi: 10.1038/sj.bjc.6604777. Epub 2008 Nov 11.
2
Hypermethylated MAL gene - a silent marker of early colon tumorigenesis.高甲基化的MAL基因——早期结肠癌发生的沉默标志物。
J Transl Med. 2008 Mar 17;6:13. doi: 10.1186/1479-5876-6-13.
3
Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis.宫颈癌变过程中启动子甲基化抑制 MAL 抑癌基因活性。
J Pathol. 2009 Nov;219(3):327-36. doi: 10.1002/path.2598.
4
T-lymphocyte maturation-associated protein gene as a candidate metastasis suppressor for head and neck squamous cell carcinomas.T淋巴细胞成熟相关蛋白基因作为头颈部鳞状细胞癌转移抑制候选基因。
Cancer Sci. 2009 May;100(5):873-80. doi: 10.1111/j.1349-7006.2009.01132.x.
5
Inactivation of the MAL gene in breast cancer is a common event that predicts benefit from adjuvant chemotherapy.乳腺癌中 MAL 基因的失活是一种常见现象,提示辅助化疗可能有效。
Mol Cancer Res. 2009 Feb;7(2):199-209. doi: 10.1158/1541-7786.MCR-08-0314. Epub 2009 Feb 10.
6
Epigenetic silencing of MAL, a putative tumor suppressor gene, can contribute to human epithelium cell carcinoma.MAL 基因的表观遗传沉默可能导致人类上皮细胞癌。
Mol Cancer. 2010 Nov 22;9:296. doi: 10.1186/1476-4598-9-296.
7
Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer.上皮性卵巢癌中 MAL 表达升高伴随着启动子低甲基化和铂类耐药。
Int J Cancer. 2010 Mar 15;126(6):1378-89. doi: 10.1002/ijc.24797.
8
Odd-skipped related 1 is a novel tumour suppressor gene and a potential prognostic biomarker in gastric cancer.奇跳相关蛋白1是一种新型肿瘤抑制基因,也是胃癌潜在的预后生物标志物。
J Pathol. 2014 Nov;234(3):302-15. doi: 10.1002/path.4391. Epub 2014 Aug 28.
9
MAL and TMEM220 are novel DNA methylation markers in human gastric cancer.MAL和TMEM220是人类胃癌中新的DNA甲基化标志物。
Biomarkers. 2017 Feb;22(1):35-44. doi: 10.1080/1354750X.2016.1201542. Epub 2016 Sep 22.
10
Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.胃癌中 DENN/MADD 结构域蛋白 2D 的表达和甲基化状态对预后的影响。
Gastric Cancer. 2015 Apr;18(2):288-96. doi: 10.1007/s10120-014-0372-0. Epub 2014 Apr 3.

引用本文的文献

1
Research advances of MAL family members in tumorigenesis and tumor progression (Review).MAL 家族成员在肿瘤发生和肿瘤进展中的研究进展(综述)。
Mol Med Rep. 2024 Apr;29(4). doi: 10.3892/mmr.2024.13181. Epub 2024 Feb 16.
2
Prostate transmembrane androgen inducible protein 1 : regulation and clinical implications.前列腺跨膜雄激素诱导蛋白1:调控及临床意义
Front Oncol. 2023 Dec 20;13:1298660. doi: 10.3389/fonc.2023.1298660. eCollection 2023.
3
Diagnosis of acute myeloid leukaemia on microarray gene expression data using categorical gradient boosted trees.

本文引用的文献

1
Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer.整合基因组和转录组分析鉴定出宫颈癌中基因表达改变的染色体位点。
Genes Chromosomes Cancer. 2008 Oct;47(10):890-905. doi: 10.1002/gcc.20590.
2
Hypermethylated MAL gene - a silent marker of early colon tumorigenesis.高甲基化的MAL基因——早期结肠癌发生的沉默标志物。
J Transl Med. 2008 Mar 17;6:13. doi: 10.1186/1479-5876-6-13.
3
Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis.人乳头瘤病毒(HPV)诱导致癌过程中AP-1及其调控基因的改变
使用分类梯度提升树通过微阵列基因表达数据诊断急性髓系白血病。
Heliyon. 2023 Oct 4;9(10):e20530. doi: 10.1016/j.heliyon.2023.e20530. eCollection 2023 Oct.
4
The MAL Family of Proteins: Normal Function, Expression in Cancer, and Potential Use as Cancer Biomarkers.MAL蛋白家族:正常功能、在癌症中的表达及作为癌症生物标志物的潜在用途。
Cancers (Basel). 2023 May 17;15(10):2801. doi: 10.3390/cancers15102801.
5
Hypermethylation-Mediated Silencing of , and Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic Studies.抑癌基因 、 、 在犬弥漫性大 B 细胞淋巴瘤中甲基化介导的沉默:从多组学分析到机制研究。
Int J Mol Sci. 2022 Apr 5;23(7):4021. doi: 10.3390/ijms23074021.
6
DNA hypermethylation of gene may act as an independent predictor of favorable prognosis in patients with colorectal cancer.基因的DNA高甲基化可能作为结直肠癌患者预后良好的独立预测指标。
Transl Cancer Res. 2019 Sep;8(5):1985-1996. doi: 10.21037/tcr.2019.09.04.
7
MAL protein suppresses the metastasis and invasion of GC cells by interfering with the phosphorylation of STAT3.MAL 蛋白通过干扰 STAT3 的磷酸化来抑制 GC 细胞的转移和侵袭。
J Transl Med. 2022 Jan 29;20(1):50. doi: 10.1186/s12967-022-03254-5.
8
Myelin and lymphocyte protein serves as a prognostic biomarker and is closely associated with the tumor microenvironment in the nephroblastoma.少突胶质细胞-淋系蛋白可作为预后生物标志物,与肾母细胞瘤肿瘤微环境密切相关。
Cancer Med. 2022 Mar;11(5):1427-1438. doi: 10.1002/cam4.4542. Epub 2022 Jan 13.
9
Myelin and Lymphocyte Protein (MAL): A Novel Biomarker for Uterine Corpus Endometrial Carcinoma.髓鞘与淋巴细胞蛋白(MAL):一种用于子宫内膜癌的新型生物标志物。
Cancer Manag Res. 2021 Sep 21;13:7311-7323. doi: 10.2147/CMAR.S317319. eCollection 2021.
10
The MAL Protein, an Integral Component of Specialized Membranes, in Normal Cells and Cancer.MAL 蛋白,一种特殊膜的基本组成部分,存在于正常细胞和癌细胞中。
Cells. 2021 Apr 30;10(5):1065. doi: 10.3390/cells10051065.
Cell Oncol. 2008;30(1):77-87. doi: 10.1155/2008/279656.
4
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer.环氧化酶-2的表观遗传沉默影响胃癌的临床结局。
J Clin Oncol. 2007 Nov 1;25(31):4887-94. doi: 10.1200/JCO.2006.09.8921.
5
DNA hypermethylation of MAL: a promising diagnostic biomarker for colorectal tumors.MAL的DNA高甲基化:一种有前景的结直肠肿瘤诊断生物标志物。
Gastroenterology. 2007 Apr;132(4):1631-2; author reply 1632. doi: 10.1053/j.gastro.2007.03.003.
6
Loss of MAL expression in precancerous lesions of the esophagus.食管癌前病变中MAL表达缺失。
Ann Surg Oncol. 2007 May;14(5):1670-7. doi: 10.1245/s10434-006-9064-2. Epub 2006 Dec 6.
7
Gastric cancers in young and elderly patients show different genomic profiles.年轻和老年患者的胃癌表现出不同的基因组特征。
J Pathol. 2007 Jan;211(1):45-51. doi: 10.1002/path.2085.
8
A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer.全基因组搜索确定了结肠癌中生长抑素、速激肽-1及其他5个基因的表观遗传沉默。
Gastroenterology. 2006 Sep;131(3):797-808. doi: 10.1053/j.gastro.2006.06.006.
9
Assessment of gene promoter hypermethylation for detection of cervical neoplasia.评估基因启动子高甲基化用于检测宫颈肿瘤。
Int J Cancer. 2006 Oct 15;119(8):1908-14. doi: 10.1002/ijc.22060.
10
MAL is expressed in a subset of Hodgkin lymphoma and identifies a population of patients with poor prognosis.MAL在一部分霍奇金淋巴瘤中表达,并可识别出预后较差的患者群体。
Am J Clin Pathol. 2006 May;125(5):776-82. doi: 10.1309/98KL-HRDA-M5CM-DHE2.